Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience
Abdullah Ozkaya, Zeynep Alkin, Mesut Togac, Sibel Ahmet, Irfan Perente, Muhittin Taskapili
Korean J Ophthalmol. 2017;31(5):424-430.   Published online 2017 Sep 11     DOI: https://doi.org/10.3341/kjo.2016.0125
Citations to this article as recorded by Crossref logo
Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression
Daniele Veritti, Valentina Sarao, Valentina Soppelsa, Carla Danese, Jay Chhablani, Paolo Lanzetta
Journal of Clinical Medicine.2022; 11(2): 325.     CrossRef
Long-Term Efficacy of a Treat-and-Extend Regimen with Ranibizumab in Patients with Neovascular Age-Related Macular Disease: An Open-Label 12-Month Extension to the CANTREAT Study
Peter J. Kertes, Tom Sheidow, Geoff Williams, Mark Greve, Ivan J. Galic, Jason Baker
Ophthalmologica.2022; 245(3): 230.     CrossRef
Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
Vincent Daien, Robert P Finger, James S Talks, Paul Mitchell, Tien Y Wong, Taiji Sakamoto, Bora M Eldem, Jean-François Korobelnik
British Journal of Ophthalmology.2021; 105(11): 1475.     CrossRef
Fluorescein angiographic characteristic in predominantly classic and occult types of neovascular age-related macular degeneration treated with ranibizumab
Cemal Çavdarlı, Sebile Çomçalı, Pınar Topcu Yılmaz, Mehmet Numan Alp
Therapeutic Advances in Ophthalmology.2021; 13: 251584142110053.     CrossRef
Bimonthly, treat‐and‐extend and as‐needed ranibizumab in naïve neovascular age‐related macular degeneration patients: 12‐month outcomes of a randomized study
María Isabel López Gálvez, Lluís Arias Barquet, Marta. S. Figueroa, Alfredo García‐Layana, José M. Ruiz Moreno, Maribel Fernandez Rodríguez, Josep García Arumí, Pedro Amat Peral, Javier Ascaso Puyuelo, Félix Armada Maresca, Enrique Cervera Taulet, Ramón T
Acta Ophthalmologica.2020;[Epub]     CrossRef
Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches
Federico Ricci, Francesco Bandello, Pierluigi Navarra, Giovanni Staurenghi, Michael Stumpp, Marco Zarbin
International Journal of Molecular Sciences.2020; 21(21): 8242.     CrossRef
Diagnosis and Treatment of Myopic Maculopathy
Asia-Pacific Journal of Ophthalmology.2019;[Epub]     CrossRef
FIVE-YEAR OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA
Yuka Onishi, Tae Yokoi, Kaori Kasahara, Takeshi Yoshida, Natsuko Nagaoka, Kosei Shinohara, Yuichiro Kaneko, Mitsuki Suga, Kengo Uramoto, Akiko Ohno-Tanaka, Kyoko Ohno-Matsui
Retina.2019; 39(7): 1289.     CrossRef
Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for wet age-related macular degeneration: A systematic review and meta-analysis
Yongxian Su, Jiawei Wu, Yu Gu
Photodiagnosis and Photodynamic Therapy.2018; 22: 263.     CrossRef